What Caught Our Attention in the Investment World? – Week of December 19-23, 2022

By Kuldip K. Ambastha On the trading days of Thursday, December 22, 2022 and Friday, December 23, 2022, the stock tickers of AMC Entertainment Holdings, Inc. (AMC and APE), a holding company with movie theaters all over the world, posted daily returns which caught Wall Street’s attention. (See past coverage if needed: “What Caught Our …

What Caught Our Attention in the Investment World? – Week of December 12-16, 2022

By Kuldip K. Ambastha On Monday, December 12, 2022, Weber Inc. (WEBR), primarily a grill (charcoal, gas, and electric) and related accessory company, had its stock price rise by +23.2% per share for the trading day. The catalyst here was a buyout offer of $8.05 per share, from a private equity firm. The company is …

What Caught Our Attention in the Investment World? – Week of November 21-25, 2022

By Kuldip K. Ambastha On Wednesday, November 23, 2022, the stock price of Coupa Software Incorporated (COUP), a technology company focused on “Business Spend Management,” shot up by +28.9% per share. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of March 14-18, 2022; By Kuldip K. Ambastha.”) The …

What Caught Our Attention in the Investment World? – Week of November 14-18, 2022

By Kuldip K. Ambastha On Thursday, November 17, 2022, the stock price of Bath & Body Works, Inc. (BBWI), a prominent specialty retail company, rose by +25.2% per share. This rise in the stock price was driven by strong 3Q2022 quarterly performance results, with earnings surpassing the expected consensus estimate. Furthermore, Bath & Body Works, …

What Caught Our Attention in the Investment World? – Week of October 31-November 4, 2022

By Kuldip K. Ambastha On the trading day of Tuesday, November 1, 2022, Johnson & Johnson (JNJ), a major pharmaceutical and medical product provider, announced plans to acquire Abiomed, Inc. (ABMD), a medical device maker. Due to this development, for that day the stock price of Abiomed rose sharply by +49.9% per share, while the …

What Caught Our Attention in the Investment World? – Week of October 24-28, 2022

By Kuldip K. Ambastha On Thursday, October 27, 2022, the stock of Credit Suisse Group AG (CS), a prominent Swiss financial institution with operations around the world, had a steep price drop of -20.0% per share for the trading day. Credit Suisse Group in the recent past has had troubles linked to the scandals around …

What Caught Our Attention in the Investment World? – Week of September 19-23, 2022

By Kuldip K. Ambastha The stock price of Sotera Health Company (SHC), an integrated global health solutions company, had a loss of -33.3% per share on Monday, September 19, 2022. On the subsequent trading days of the week, three negative daily returns and one positive daily return were seen. Litigation was the primary cause of …

What Caught Our Attention in the Investment World? – Week of September 6-9, 2022

By Kuldip K. Ambastha The stock of Regeneron Pharmaceuticals, Inc. (REGN), a biotechnology company with a portfolio of medicines for individuals with serious diseases, increased in price by +18.8% per share on the trading day of Thursday, September 8, 2022. Eylea (aka: aflibercept), an anti-blindness eye medication, was the cause of this price run-up, because …

What Caught Our Attention in the Investment World? – Week of August 29-September 2, 2022

By Kuldip K. Ambastha On Thursday, September 1, 2022, the stock of Okta, Inc. (OKTA), a technology company providing cloud-based identity management support for businesses, fell in price by -33.7% per share for the trading day. While 2Q2022 results surpassed Wall Street expectations, areas of concern on a going forward basis drove this sharp decline …

What Caught Our Attention in the Investment World? – Week of August 8-12, 2022

By Kuldip K. Ambastha The stock of VIZIO Holding Corp. (VZIO), a company involved in designing and manufacturing consumer electronics, had a +18.1% per share rise in price on Thursday, August 11, 2022. For 2Q2022, the company’s sales did not match or exceed Wall Street equity research analyst expectations. However, the company also delivered a …